Skip to Content
Merck
CN

9-Dihydroerythromycins as non-antibiotic motilin receptor agonists.

Bioorganic & medicinal chemistry letters (2010-08-31)
Yaoquan Liu, Yong Li, Yue Chen, Hao Zheng, Mark Claypool, David C Myles, Christopher W Carreras
ABSTRACT

A series of 9-dihydroerythromycin A and B analogues with modification of the desosamine nitrogen have been synthesized and screened for motilin agonist activity, antibiotic activity, tachyphylaxis and hERG channel current inhibition. Small alkyl groups resulted in the potency while compounds with a primary or secondary amine resulted in the low motilin agonist potency. Several compounds were identified as non-antibiotic motilin receptor agonists with minimal tachyphylaxis and low hERG interaction.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Erythromycin, tested according to Ph. Eur.
Sigma-Aldrich
Erythromycin, BioReagent, suitable for cell culture
Sigma-Aldrich
Erythromycin, potency: ≥850 μg per mg
Sigma-Aldrich
Erythromycin, meets USP testing specifications